Literature DB >> 26585163

Molecular Design, Synthesis, and Evaluation of SNIPER(ER) That Induces Proteasomal Degradation of ERα.

Keiichiro Okuhira1, Yosuke Demizu2, Takayuki Hattori1, Nobumichi Ohoka1, Norihito Shibata1, Masaaki Kurihara2, Mikihiko Naito3.   

Abstract

Manipulation of protein stability using small molecules has a great potential for both basic research and clinical therapy. Based on our protein knockdown technology, we recently developed a novel small molecule SNIPER(ER) that targets the estrogen receptor alpha (ERα) for degradation via the ubiquitin-proteasome system. This chapter describes the design and synthesis of SNIPER(ER) compounds, and methods for the evaluation of their activity in cellular system.

Entities:  

Keywords:  Cell death; Estrogen receptor; Protein knockdown; SNIPER; Ubiquitin–proteasome system

Mesh:

Substances:

Year:  2016        PMID: 26585163     DOI: 10.1007/978-1-4939-3127-9_42

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

Review 1.  Targeted Protein Degradation by Small Molecules.

Authors:  Daniel P Bondeson; Craig M Crews
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016-10-12       Impact factor: 13.820

2.  Targeting the Allosteric Site of Oncoprotein BCR-ABL as an Alternative Strategy for Effective Target Protein Degradation.

Authors:  Kenichiro Shimokawa; Norihito Shibata; Tomoya Sameshima; Naoki Miyamoto; Osamu Ujikawa; Hiroshi Nara; Nobumichi Ohoka; Takayuki Hattori; Nobuo Cho; Mikihiko Naito
Journal:  ACS Med Chem Lett       Date:  2017-09-14       Impact factor: 4.345

3.  SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib.

Authors:  Nobumichi Ohoka; Katsunori Nagai; Norihito Shibata; Takayuki Hattori; Hiroshi Nara; Nobuo Cho; Mikihiko Naito
Journal:  Cancer Sci       Date:  2017-04-26       Impact factor: 6.716

Review 4.  Targeting protein quality control pathways in breast cancer.

Authors:  Sara Sannino; Jeffrey L Brodsky
Journal:  BMC Biol       Date:  2017-11-16       Impact factor: 7.431

Review 5.  Major Advances in Targeted Protein Degradation: PROTACs, LYTACs, and MADTACs.

Authors:  Shanique Alabi; Craig Crews
Journal:  J Biol Chem       Date:  2021-04-08       Impact factor: 5.157

Review 6.  Targeting Oncoproteins for Degradation by Small Molecule-Based Proteolysis-Targeting Chimeras (PROTACs) in Sex Hormone-Dependent Cancers.

Authors:  Li Liu; Lihong Shi; Zhaodi Wang; Jun Zeng; Yue Wang; Hongtao Xiao; Yongxia Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-18       Impact factor: 5.555

Review 7.  Advancing targeted protein degradation for cancer therapy.

Authors:  Brandon Dale; Meng Cheng; Kwang-Su Park; H Ümit Kaniskan; Yue Xiong; Jian Jin
Journal:  Nat Rev Cancer       Date:  2021-06-15       Impact factor: 60.716

Review 8.  E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points.

Authors:  Aleša Bricelj; Christian Steinebach; Robert Kuchta; Michael Gütschow; Izidor Sosič
Journal:  Front Chem       Date:  2021-07-05       Impact factor: 5.221

Review 9.  The PROTAC technology in drug development.

Authors:  Yutian Zou; Danhui Ma; Yinyin Wang
Journal:  Cell Biochem Funct       Date:  2019-01-02       Impact factor: 3.685

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.